Stock listing

Munich:4VF SinoMab Bioscience Ltd. Aktie

German listing (Munich) of SinoMab Bioscience Ltd. · home listing HKEX:3681

Follow SinoMab Bioscience Ltd. into a list and get an email when it puts out news.

Home listing price · HKEX:3681

$0.94 HKD 0.00 (0.0%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, HKEX:3681

Past year -43.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.92 – $0.945 HKDNov 20, 2026
Volume
699,900 sharesNov 20, 2026
Market cap
$1.30B HKDAt the close on Nov 20, 2026 · price × 1.39B shares outstanding
52-week range
$0.92 – $2.19 HKDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$741,009 HKDMedian day 459,150 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
SinoMab Bioscience Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
HKEX:3681 · Home$0.94 HKD0.00 (0.0%)699,900$0.94$0.945$0.92$0.94Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:3681 · HKD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.940.000.0%$0.94$0.945$0.92699,900
$0.94-0.055-5.5%$1.00$1.01$0.9489,100
$0.995+0.035+3.6%$0.95$0.995$0.94381,000
$0.96+0.005+0.5%$0.955$1.00$0.955461,700
$0.955-0.045-4.5%$1.00$1.00$0.955384,900
$1.000.000.0%$1.00$1.03$0.985456,600
$1.00-0.02-2.0%$1.00$1.01$0.9947,700
$1.02+0.03+3.0%$1.03$1.03$1.02600
$0.99-0.01-1.0%$0.98$1.00$0.98200,100
$1.00-0.01-1.0%$1.01$1.01$0.985233,400
$1.01-0.015-1.5%$1.005$1.055$0.9952,247,000
$1.025+0.025+2.5%$1.00$1.025$1.00392,400
$1.00-0.015-1.5%$1.005$1.015$0.9651,961,700
$1.015-0.055-5.1%$1.03$1.05$1.005590,400
$1.07+0.05+4.9%$1.005$1.07$1.00342,300
$1.02-0.05-4.7%$1.05$1.05$1.01359,700
$1.07+0.05+4.9%$1.025$1.075$1.025213,900
$1.02-0.03-2.9%$1.05$1.06$1.02208,500
$1.050.000.0%$1.05$1.06$1.04262,500
$1.05-0.065-5.8%$1.055$1.055$1.015561,900
$1.115+0.04+3.7%$1.075$1.115$1.03216,600
$1.075-0.005-0.5%$1.075$1.08$1.07127,500
$1.08-0.02-1.8%$1.10$1.10$1.0869,900
$1.10-0.07-6.0%$1.155$1.155$1.05660,600
$1.17+0.065+5.9%$1.105$1.17$1.065647,100
$1.105+0.005+0.5%$1.115$1.22$1.0951,079,400
$1.10-0.05-4.3%$1.13$1.14$1.09984,300
$1.150.000.0%$1.15$1.24$1.1251,852,200
$1.15+0.08+7.5%$1.10$1.15$1.0951,372,200
$1.07+0.015+1.4%$1.05$1.13$1.041,660,500
$1.055+0.01+1.0%$1.05$1.06$1.03573,300
$1.045+0.03+3.0%$1.00$1.05$1.0083,700
$1.015+0.005+0.5%$1.00$1.05$1.00275,100
$1.01+0.01+1.0%$1.00$1.02$0.975329,700
$1.000.000.0%$1.00$1.03$0.985794,100
$1.00-0.02-2.0%$1.00$1.02$0.99666,300
$1.02+0.02+2.0%$1.00$1.02$0.961,404,900
$1.00-0.05-4.8%$1.055$1.065$1.002,837,100
$1.05-0.045-4.1%$1.095$1.11$1.04829,200
$1.095-0.015-1.4%$1.11$1.11$1.0883,400
$1.11-0.005-0.4%$1.11$1.11$1.065349,800
$1.115-0.01-0.9%$1.145$1.145$1.10515,700
$1.125-0.025-2.2%$1.15$1.15$1.10299,100
$1.15+0.02+1.8%$1.12$1.15$1.105381,000
$1.13+0.025+2.3%$1.115$1.145$1.0851,151,100
$1.105+0.005+0.5%$1.10$1.12$1.065739,500
$1.100.000.0%$1.10$1.125$1.08328,200
$1.10+0.02+1.9%$1.085$1.135$1.075402,900
$1.08-0.04-3.6%$1.115$1.115$1.075325,200
$1.120.000.0%$1.10$1.14$1.10637,500
$1.12-0.025-2.2%$1.125$1.15$1.115548,400
$1.145-0.005-0.4%$1.10$1.155$1.10294,900
$1.15+0.01+0.9%$1.14$1.16$1.12146,700
$1.14+0.04+3.6%$1.08$1.145$1.065705,600
$1.10+0.025+2.3%$1.075$1.11$1.06176,400
$1.075-0.025-2.3%$1.08$1.11$1.0752,555,700
$1.10+0.025+2.3%$1.075$1.12$1.03666,000
$1.075-0.015-1.4%$1.105$1.105$1.061,237,800
$1.09-0.02-1.8%$1.09$1.095$1.051,019,100
$1.11+0.01+0.9%$1.10$1.15$1.10248,400
$1.10-0.01-0.9%$1.11$1.125$1.08126,300
$1.11-0.01-0.9%$1.12$1.135$1.051,076,700
$1.12-0.08-6.7%$1.19$1.20$1.092,924,700
$1.20-0.02-1.6%$1.245$1.25$1.17781,200
Ticker
Munich:4VF
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Munich
Currency
EUR

What changed lately

Latest news

All SinoMab Bioscience Ltd. news

SinoMab Bioscience Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
8 in the last 12 months · 8 in all · newest Nov 5, 2026 · oldest 2026

Where SinoMab Bioscience Ltd. is listed

ListingExchangeCountryCurrency
HKEX:3681 中國抗體 · Home listingHKEXHong KongHKD
gettex:4VFgettexGermanyEUR
LS Exchange:A2PURULS ExchangeGermanyEUR
Dusseldorf:4VFDusseldorfGermanyEUR
Frankfurt:4VFFrankfurtGermanyEUR
Lang & Schwarz:A2PURULang & SchwarzGermanyEUR
Munich:4VF · This pageMunichGermanyEUR
Tradegate:4VFTradegateGermanyEUR

Valuation

Price/book 3.1× against a median of 2.1×: 7th lowest of 11 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$1.35B HKD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
3.1×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.7×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
SinoMab Bioscience Ltd. · HKEX:3681US$166.3MUS$172.4Mn/an/an/a3.1×n/a0.7×n/a
MediWound Ltd. · NASDAQ:MDWDUS$175.5MUS$155.9Mn/a15.6×n/a5.5×−235.0%0.3×0.64
Nanexa AB · OMXSTO:NANEXAUS$175.1MUS$170.1Mn/a51.4×n/a13.5×−72.5%0.0×n/a
Compugen Ltd. · NASDAQ:CGENUS$174.3MUS$59.55M4.8×0.8×n/a2.1×47.9%0.0×1.49
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H · HKEX:2591US$170.8MUS$40.22Mn/a2.1×n/a1.2×−259.6%0.2×n/a
Entrada Therapeutics, Inc. · NASDAQ:TRDAUS$170.3MUS$24.60Mn/a6.2×n/a0.9×n/a0.2×1.43
Prestige BioPharma Limited · KRX:950210US$165.8MUS$132.7Mn/a6.8×n/a0.5×−350.9%0.1×n/a
Acepodia, Inc. · TPEX:6976US$162.7MUS$58.46Mn/a10,415×n/a1.1×n/a0.0×n/a
TaiGen Biopharmaceuticals Holdings Limited · TPEX:4157US$161.1MUS$133.4M34.2×17.1×46.8×5.2×60.5%0.0×n/a
ImmuneOncia Therapeutics Inc. · KRX:424870US$160.0MUS$90.35Mn/an/an/a2.1×n/a0.0×n/a
Baijin Life Science Holdings Limited · HKEX:1466US$160.0MUS$158.1Mn/a13.9×n/a6.8×−42.4%0.1×n/a
Median of the othersUS$168.0MUS$111.5M19.5×13.9×46.8×2.1×−72.5%0.0×1.43

Events

QuarterResultsShare move
Q2 2025Aug 29, 2025−2.6%
Quarter to Mar 31, 2025Jun 13, 2025 · Before open−10.2%
Q4 2024Mar 31, 2025−3.7%

Open Events

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue02.03M1.36M4.03M26.7M12.8M01.48M0
Cost of revenue26.6M1.48M943.0K0743.0K117.0K
Gross profit-26.6M543.0K422.0K4.03M26.7M12.8M1.48M-117.0K
Research and development79.5M94.8M135.4M180.4M199.1M103.4M214.3M47.3M32.6M
Selling, general and administrative46.4M67.7M97.4M82.4M131.9M71.1M61.5M2.01M991.0K
Operating income-124.7M-161.4M-229.6M-258.9M-305.9M-162.7M-273.9M-54.8M-39.6M
Depreciation and amortization27.3M29.0M36.1M28.0M20.7M10.7M8.49M5.34M4.92M
EBITDA-97.4M-132.3M-193.5M-230.9M-285.2M-152.0M-265.5M-49.5M-34.7M
Interest expense5.38M8.66M6.58M31.9M5.82M2.42M2.34M3.03M2.96M
Income before tax-102.3M-185.1M-243.1M-284.2M-288.2M-122.6M-276.3M-83.6M-51.9M
Income tax2.34M
Net income-102.3M-185.1M-243.1M-284.2M-288.2M-122.6M-278.6M-83.6M-48.0M
Earnings per share, basic-0.08-0.17-0.24-0.29-0.29-0.12-0.33-0.08-0.05

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents333.7M61.9M203.7M345.7M563.0M810.4M1.20B41.5M66.1M
Short-term investments48.7M45.0M31.0M46.2M26.5M93.1M6.49M1.10M46.8M
Receivables6.09M259.0K
Current assets390.1M185.3M270.2M447.1M595.7M934.4M1.22B50.3M126.8M
Property, plant and equipment501.0M566.0M574.7M485.8M356.2M145.9M42.2M38.4M34.7M
Total assets908.5M753.1M847.8M1.01B1.04B1.13B1.28B88.8M161.6M
Current liabilities204.1M203.5M172.6M187.4M98.4M58.8M106.7M28.4M184.9M
Long-term debt192.1M306.6M324.8M238.4M193.8M55.5M20.3M
Total debt338.6M482.3M450.8M357.2M275.5M88.7M53.6M60.3M212.0M
Total liabilities400.4M560.2M552.2M498.8M361.4M142.5M152.2M61.4M212.6M
Shareholders' equity508.1M192.9M295.6M509.6M680.2M987.0M1.13B27.4M-51.0M
Shares outstanding1.23B1.07B1.02B992.0M994.9M1.01B836.7M1.01B1.01B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-70.5M-130.8M-133.8M-300.5M-147.1M-141.3M-222.5M-46.8M-40.2M
Capital spending-25.3M-41.5M-103.9M-112.8M-198.2M-76.0M-42.3M-2.75M-823.0K
Free cash flow-95.8M-172.3M-237.7M-413.3M-345.3M-217.3M-264.8M-49.6M-41.0M
Cash from investing16.3M-94.5M-96.9M-81.4M-137.7M-179.2M-42.3M21.5M10.3M
Cash from financing329.4M73.3M82.3M102.3M57.5M-18.8M1.42B-3.56M89.0M
Share buybacks54.8M10.0M46.1M-59.7M01.43B148.9M35.0K
Change in cash260.8M-141.8M-139.2M-220.1M-247.4M-390.5M1.16B-24.6M57.7M

Open Financials

Filings

Open Filings

Cap table

Built by 6ix from SinoMab Bioscience Ltd.’s releases

Common shares
1,386,638,336
Fully diluted
1,386,638,336

Fully diluted

LineShares
Common shares1,386,638,336

Share count over time

CountShares
Nov 22, 20261,386,638,336

Open Cap table

Shareholders

HolderSharesOf the companyAs of
海南海药股份有限公司152M15.1%Nov 12, 2019
Hainan Haiyao Co. Ltd.159M14.6%Apr 1, 2024
Skytech Technology Limited130M9.5%Aug 15, 2025
LEUNG Shui On130M9.5%Aug 15, 2025
Liu Wenyi123M8.9%Oct 16, 2025
QIANG Jing123M8.9%Oct 16, 2025
上海杏泽投资管理有限公司110M7.9%Jan 12, 2026
上海月溢投资中心(有限合伙)110M7.9%Jan 12, 2026
Apricot Oversea Holdings Limited72.2M6.0%Jun 23, 2025

Open Shareholders

Log in to ask 6ix AI your own questions about SinoMab Bioscience Ltd.